Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

Share "Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study"

N/A

Protected

Studieår: 2022

Info

Nedlasting

Protected

Academic year: 2022

Share "Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study"

Copied!

Laster.... (Se fulltekst nå)

Last ned nå ( 15 sider )

Fulltekst

Referanser

Last ned nå ( PDF - 15 sider - 2.83 MB )

RELATERTE DOKUMENTER

How do women with chronic fatigue syndrome/myalgic encephalomyelitis rate quality and coordination of health care services? A cross-sectional study

Our aim was to study how patients with CFS/ME rated healthcare quality and coordination of services, and to investigate whether self-rated health and self-rated degree of CFS/ME

RELATERTE DOKUMENTER

Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study

Genetic study of T cell receptor (TCR) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

108

Experiences of general practitioner continuity among women with chronic fatigue syndrome/myalgic encephalomyelitis: a cross-sectional study

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study

PMID: 26672998 Experiences of general practitioner continuity among women with chronic fatigue syndrome/myalgic encephalomyelitis: a cross-sectional study

Human Leukocyte Antigen alleles associated with Myalgic encephalomyelitis/chronic fatigue Syndrome (Me/cfS)

Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci

Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)